Form 8-K - Current report:
SEC Accession No. 0001437749-25-016131
Filing Date
2025-05-12
Accepted
2025-05-12 16:29:50
Documents
20
Period of Report
2025-05-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K crvo20250509_8k.htm   iXBRL 8-K 39012
2 EXHIBIT 1.1 ex_815690.htm EX-1.1 283620
3 EXHIBIT 5.1 ex_815691.htm EX-5.1 12862
4 EXHIBIT 99.1 ex_816257.htm EX-99.1 96287
9 logosmlr.jpg GRAPHIC 3845
10 mlogo.jpg GRAPHIC 6719
11 mlogo_sm.jpg GRAPHIC 3562
  Complete submission text file 0001437749-25-016131.txt   678028

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA crvo-20250512.xsd EX-101.SCH 3579
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20250512_def.xml EX-101.DEF 11807
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20250512_lab.xml EX-101.LAB 15858
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20250512_pre.xml EX-101.PRE 12022
22 EXTRACTED XBRL INSTANCE DOCUMENT crvo20250509_8k_htm.xml XML 2929
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 25935303
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)